Botulinum Toxin Serotype A randomized double-blind, placebo controlled multicentre study for degenerative coxarthrosis. Studio randomizzato, multicentrico, in doppio cieco controllato con placebo sull'impiego di tossina botulinica di tipo A, nel trattamento della coxartrosi degenerativa.

Trial Profile

Botulinum Toxin Serotype A randomized double-blind, placebo controlled multicentre study for degenerative coxarthrosis. Studio randomizzato, multicentrico, in doppio cieco controllato con placebo sull'impiego di tossina botulinica di tipo A, nel trattamento della coxartrosi degenerativa.

Completed
Phase of Trial: Phase III

Latest Information Update: 01 Apr 2016

At a glance

  • Drugs Botulinum toxin A (Primary)
  • Indications Osteoarthritis
  • Focus Therapeutic Use
  • Acronyms BOLD
  • Most Recent Events

    • 01 Apr 2016 Status changed from recruiting to completed as reported by European Clinical Trials Database record.
    • 20 Jun 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top